"Designing Growth Strategies is in our DNA"

Antipsychotic Drugs Market Size, Share & Industry Analysis, By Disease (Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, and Others), By Drug (Risperidone, Quetiapine, Olanzapine, Aripiprazole, Brexpiprazole, Paliperidone Palmitate, and Others), By Therapeutic Class (First Generation, Second Generation, and Third Generation), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2024-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI101390

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2023

Estimated Year

2024

Forecast Period

2024-2032

Historical Period

2019-2022

Growth Rate

CAGR of 5.4% from 2024-2032

Unit

Value (USD billion)

Segmentation

By Disease

  • Schizophrenia
  • Bipolar Disorder
  • Unipolar Depression
  • Dementia
  • Others

By Drug

  • Risperidone
  • Quetiapine
  • Olanzapine
  • Aripiprazole
  • Brexpiprazole
  • Paliperidone Palmitate
  • Others

By Therapeutic Class

  • First Generation
  • Second Generation
  • Third Generation

By Distribution Channel

  • Hospital Pharmacies
  • Drug Stores & Retail Pharmacies
  • Online Pharmacies

By Region

  • North America (By Disease, By Drug, By Therapeutic Class, By Distribution Channel, By Country)
    • U.S. (By Disease)
    • Canada (By Disease)
  • Europe (By Disease, By Drug, By Therapeutic Class, By Distribution Channel, By Country/Sub-Region)
    • Germany (By Disease)
    • U.K. (By Disease)
    • France (By Disease)
    • Italy (By Disease)
    • Spain (By Disease)
    • Scandinavia (By Disease)
    • Rest of Europe (By Disease)
  • Asia Pacific (By Disease, By Drug, By Therapeutic Class, By Distribution Channel, By Country/Sub-Region)
    • China (By Disease)
    • Japan (By Disease)
    • India (By Disease)
    • Australia (By Disease)
    • Southeast Asia (By Disease)
    • Rest of Asia Pacific (By Disease)
  • Latin America (By Disease, By Drug, By Therapeutic Class, By Distribution Channel, By Country/Sub-Region)
    • Brazil (By Disease)
    • Mexico (By Disease)
    • Rest of Latin America (By Disease)
  • Middle East & Africa (By Disease, By Drug, By Therapeutic Class, By Distribution Channel, By Country/Sub-Region)
    • GCC (By Disease)
    • South Africa (By Disease)
    • Rest of Middle East & Africa (By Disease)
  • 2019-2032
  • 2023
  • 2019-2022
  • 195
  • Buy Now

    (Offer valid till 15th Dec 2025)

Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann